These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9807893

  • 1. [Flutamide, an alternative for patients with benign prostatic hyperplasia (BPH) that cannot be treated with surgery].
    Granados EA.
    Arch Esp Urol; 1998 Sep; 51(7):675-9. PubMed ID: 9807893
    [Abstract] [Full Text] [Related]

  • 2. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H, Yano M, Awa Y, Nakatsu H, Egoshi K, Mikami K, Ota S, Okano T, Hamano S, Ohki T, Furuya Y, Ichikawa T.
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [Abstract] [Full Text] [Related]

  • 3. [The anti-androgen flutamide in the treatment of prostatic hyperplasia].
    Romics I, Bach D.
    Orv Hetil; 1992 Nov 22; 133(47):3023-5. PubMed ID: 1279497
    [Abstract] [Full Text] [Related]

  • 4. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA.
    Arch Esp Urol; 1999 Apr 22; 52(3):201-8. PubMed ID: 10371735
    [Abstract] [Full Text] [Related]

  • 5. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S, Sciarra F, Adamo MV, Toscano V, Trotta MC, Martini C, Lanzara S, Silverio FD.
    J Androl; 1997 Apr 22; 18(5):488-94. PubMed ID: 9349746
    [Abstract] [Full Text] [Related]

  • 6. Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.
    Stone NN, Clejan SJ.
    J Androl; 1991 Apr 22; 12(6):376-80. PubMed ID: 1722793
    [Abstract] [Full Text] [Related]

  • 7. [Hormonal therapy of benign prostatic hyperplasia].
    Horninger W, Bartsch G.
    Urologe A; 1995 Jan 22; 34(1):9-15. PubMed ID: 7533450
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates.
    Kuo HC.
    Urology; 2005 Apr 22; 65(4):670-4. PubMed ID: 15833506
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M, Lukacs B, Matzkin H, Alcaraz A, Elhilali M, Vallancien G.
    J Urol; 2006 Sep 22; 176(3):1051-6. PubMed ID: 16890690
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia].
    Cheng NZ, Tang ZY, Liu Y, Liu XS, Qi L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct 22; 33(10):975-8. PubMed ID: 19001744
    [Abstract] [Full Text] [Related]

  • 14. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK, Garcia L, Patron N, Moh LC, Sundram M, Leungwattanakij S, Pripatnanont C, Cheng C, Chi-Wai M, Loi-Cheong N.
    BJU Int; 2008 Jan 22; 101(2):197-202. PubMed ID: 18005205
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L, Romero J, López C, Ortiz M, Pacheco JJ.
    Urol Int; 2008 Jan 22; 81(1):66-71. PubMed ID: 18645274
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
    Le Gal S, Fouques Y, Mallick S, Taksin L, Le Toquin-Bernard S, Frachet O, Bensadoun H.
    Prog Urol; 2009 May 22; 19(5):327-32. PubMed ID: 19393538
    [Abstract] [Full Text] [Related]

  • 19. [The use of serpens for treating patients with benign prostatic hyperplasia].
    Mazo EB, Chekhonin VP, Riabukhin IA, Grigor'ev ME.
    Ter Arkh; 1996 May 22; 68(10):47-9. PubMed ID: 9026943
    [Abstract] [Full Text] [Related]

  • 20. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
    Vallancien G, Emberton M, Alcaraz A, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Elhilali M, ALF-ONE Study Group.
    BJU Int; 2008 Apr 22; 101(7):847-52. PubMed ID: 18321317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.